Alpha Teknova (TKNO) Total Non-Current Liabilities (2020 - 2025)
Alpha Teknova (TKNO) posted quarterly Total Non-Current Liabilities of $34.8 million for Q4 2025, down 4.28% year-over-year from $36.4 million in Q4 2024, and little changed quarter-over-quarter from $35.0 million in Q3 2025.
Alpha Teknova (TKNO) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Alpha Teknova (TKNO) has reported Total Non-Current Liabilities for 6 consecutive years, with $34.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Non-Current Liabilities fell 4.28% year-over-year to $34.8 million; the TTM figure through Dec 2025 stood at $34.8 million (down 4.28% YoY), while the FY2025 annual figure was $34.8 million, down 4.28% from the prior year.
- Total Non-Current Liabilities steadied at $34.8 million in Q4 2025 per TKNO's latest filing, from $35.0 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $52.2 million in Q4 2022 and bottomed at $22.6 million in Q3 2021.
- Historically, Total Non-Current Liabilities has averaged $38.0 million across 5 years, with a median of $36.8 million in 2024.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities jumped 126.81% — and 2023, when it dropped 26.32%.
- Alpha Teknova's Total Non-Current Liabilities stood at $23.0 million in 2021, then soared by 126.55% to $52.2 million in 2022, then fell by 26.32% to $38.4 million in 2023, then decreased by 5.42% to $36.4 million in 2024, then decreased by 4.28% to $34.8 million in 2025.
- Business Quant data shows TKNO's Total Non-Current Liabilities at $34.8 million in Q4 2025, $35.0 million in Q3 2025, and $34.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 334.00 Mn |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.81 Mn |
| Sep 30, 2025 | 34.98 Mn |
| Jun 30, 2025 | 34.43 Mn |
| Mar 31, 2025 | 35.39 Mn |
| Dec 31, 2024 | 36.37 Mn |
| Sep 30, 2024 | 36.80 Mn |
| Jun 30, 2024 | 36.37 Mn |
| Mar 31, 2024 | 37.36 Mn |
| Dec 31, 2023 | 38.45 Mn |
| Sep 30, 2023 | 38.61 Mn |
| Jun 30, 2023 | 46.19 Mn |
| Mar 31, 2023 | 48.77 Mn |
| Dec 31, 2022 | 52.19 Mn |
| Sep 30, 2022 | 48.06 Mn |
| Jun 30, 2022 | 48.50 Mn |
| Mar 31, 2022 | 45.28 Mn |
| Dec 31, 2021 | 23.04 Mn |
| Sep 30, 2021 | 22.64 Mn |
| Jun 30, 2021 | 23.22 Mn |
| Dec 31, 2020 | 10.16 Mn |